Literature DB >> 18609051

Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure: result of a randomised cross-over study of the effects on health-related quality of life, physical capacity, thirst and morbidity.

Marie Holst1, Anna Strömberg, Maud Lindholm, Ronnie Willenheimer.   

Abstract

OBJECTIVE: To compare the effects of a restrictive versus a liberal fluid prescription, on quality of life, physical capacity, thirst and hospital admissions, in patients who had improved from NYHA class (III-)IV CHF to a stable condition without clinical signs of significant fluid overload.
DESIGN: The present study is a randomised cross-over study. Seventy-four patients (mean age 70+/-10 years, 16% women) -- with mild-moderate CHF -- were randomised 1:1 to either of two 16-week interventions. Intervention 1 prescribed a maximum fluid intake of 1.5 L/day. Intervention 2 prescribed a maximum fluid intake of 30-35 ml/kg body weight/day. Sixty-five patients completed the study.
RESULTS: There were no significant between-intervention differences in end-of-intervention quality of life, physical capacity or hospitalisation. However, there was a significant favourable effect on thirst and less difficulties to adhere to the fluid prescription during the liberal fluid prescription intervention.
CONCLUSION: The results from this study indicate that it may be beneficial and safe to recommend a liberal fluid prescription, based on body weight, in stabilised CHF patients. These results warrant further investigation of the effects of fluid advice in CHF.

Entities:  

Mesh:

Year:  2008        PMID: 18609051     DOI: 10.1080/14017430802071200

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  11 in total

1.  Gaps in the Heart Failure Guidelines.

Authors:  Bao Tran; Gregg C Fonarow
Journal:  Card Fail Rev       Date:  2015-04

Review 2.  Dietary Self-management in Heart Failure: High Tech or High Touch?

Authors:  Eloisa Colin-Ramirez; JoAnne Arcand; Justin A Ezekowitz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

Review 3.  Gaps in the Heart Failure Guidelines.

Authors:  Bao Tran; Gregg C Fonarow
Journal:  Eur Cardiol       Date:  2014-12

Review 4.  Effects of limiting fluid intake on clinical and laboratory outcomes in patients with heart failure. Results of a meta-analysis of randomized controlled trials.

Authors:  R De Vecchis; C Baldi; C Cioppa; A Giasi; A Fusco
Journal:  Herz       Date:  2015-08-21       Impact factor: 1.443

5.  Patient-stated preferences regarding volume-related risk mitigation strategies for hemodialysis.

Authors:  Jennifer E Flythe; Thomas W Mangione; Steven M Brunelli; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

Review 6.  Causes and treatment of oedema in patients with heart failure.

Authors:  Andrew L Clark; John G F Cleland
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

7.  Thirst in stable heart failure patients; time to reconsider fluid restriction and prescribed diuretics.

Authors:  Martje H L van der Wal; Tiny Jaarsma; Lieset C Jenneboer; Gerard C M Linssen
Journal:  ESC Heart Fail       Date:  2022-05-12

8.  Association between fluid intake and mortality in critically ill patients with negative fluid balance: a retrospective cohort study.

Authors:  Yanfei Shen; Xinmei Huang; Weimin Zhang
Journal:  Crit Care       Date:  2017-05-12       Impact factor: 9.097

9.  Frequent drinking of small volumes improves cardiac function and survival in rats with chronic heart failure.

Authors:  Can Zheng; Meihua Li; Toru Kawada; Masashi Inagaki; Kazunori Uemura; Masaru Sugimachi
Journal:  Physiol Rep       Date:  2017-11

10.  Isolating the benefits of fluid restriction in patients with heart failure: A pilot study.

Authors:  Carolyn Miller Reilly; Melinda Higgins; Andrew Smith; Steven D Culler; Sandra B Dunbar
Journal:  Eur J Cardiovasc Nurs       Date:  2014-07-02       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.